EUVIMED · CrossrefZeitschrift
Neurology Neuroimmunology & Neuroinflammation
ISSN 2332-7812 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Multiple Sclerosis Relapses Are Associated With EBV-Specific T-Cell Expansion Amid Broad Immune Activation
Biomarker Synergy in Relapsing Multiple Sclerosis
Patient-Reported Experiences of Long-Term Recovery and Persistent Psychosocial Burden in NMDAR Encephalitis
Epstein-Barr Virus Serologic Profiles in Multiple Sclerosis and Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Genetic Variation Underlying CSF Natural Killer T-Cell Frequency in Inflammatory CNS Diseases
Lowering the Barr
CSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern
Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies
Evaluating the Clinical Utility of TSPO-PET in MS and the Influence of Methodological Heterogeneity
Double-Negative Neuromyelitis Optica Spectrum Disorder
Use of Fluid Biomarkers in NMOSD and MOGAD
Kappa Free Light Chain for Diagnosis and Neurofilament Light Chain for Prognosis in Autoimmune Encephalitis
CSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern
HTLV-1–Infected CD4 + T Cells Drive Spontaneous Lymphoproliferation and Virus-Specific CD8 + Cytotoxic T Lymphocyte Expansion in HAM/TSP
Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis
Brain Immune Cell Composition in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy After Natalizumab
Clinical Spectrum of Anti-SEZ6L2 Syndrome
Low Prevalence and Inconsistency of LRP4-IgG Detection in Suspected Myasthenia Gravis
Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder
Decoding TREM2 Signaling Pathways
Progression Independent of Relapse Activity in Aquaporin-4-IgG–Positive NMOSD
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments
Systematic Review and Meta-Analysis of the Clinical Features Associated With Seronegative Autoimmune Encephalitis
Aberrant Complement Activation Is a Prominent Feature of Chronic Inflammatory Demyelinating Polyneuropathy
EBV Dysregulation Is Associated With Immune Imbalance in Multiple Sclerosis
Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks
Promising Effects of CAR T-Cell Therapy in Refractory Stiff Person Syndrome and a Hopeful Future for All Neuroautoimmunities
Movement Disorders in Antibody-Associated Neurologic Diseases
EUVIMED